Crown Bioscience Expands Genomics and Next Generation Sequencing (NGS) Capabilities To Streamline Translational Biomarker Discovery Workflows
Crown Bioscience Monday, January 11, 2021 10:00AM IST (4:30AM GMT) San Diego, United States: Crown Bioscience, a JSR Life Sciences company, today announced the expansion of their state-of-the-art NGS capabilities, together with the launch of proprietary NGS panel services, providing increased opportunities for pharmaceutical partners to better understand drug mechanisms of action (MOA) and to develop predictive biomarkers for their investigational drug candidates. (Graphic: Business Wire) The newly built, comprehensive suite...
Source: businesswireindia.com